Bulletin
Investor Alert

New York Markets Open in:

Nuvation Bio Inc.

NYS: NUVB

GO
/marketstate/country/us

After Hours

/zigman2/quotes/220091137/composite

$

10.80

Change

+0.11 +1.03%

Volume

Volume 4,202

Apr 13, 2021, 7:34 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/220091137/composite

Previous close

$ 9.49

$ 10.69

Change

+1.20 +12.64%

Day low

Day high

$9.40

$10.81

Open
Open: 9.55

52 week low

52 week high

$8.56

$15.08

Open

Market cap

$2.07B

Average volume

997,804

P/E ratio

N/A

Rev. per Employee

N/A

EPS

N/A

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nuvb

MarketWatch News on NUVB

  1. Nuvation Bio started at outperform with $16 stock price target at BMO Capital

    11:22 a.m. March 8, 2021

    - Tomi Kilgore

  2. Nuvation Bio started at outperform with $20 stock price target at Wedbush

    8:28 a.m. March 8, 2021

    - Tomi Kilgore

/news/nonmarketwatch/company/us/nuvb

Other News on NUVB

  1. Panacea Acquisition II prices $150M SPAC IPO in biotech space

    9:15 a.m. April 7, 2021

    - Seeking Alpha

  2. Nuvation Bio's NUV-422 wins FDA 'Orphan Drug' status

    9:00 a.m. March 11, 2021

    - Seeking Alpha

  3. 10-Q: PANACEA ACQUISITION CORP

    11:08 a.m. Nov. 16, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. Investors Pump Billions into Biotech Startups

    10:06 a.m. Oct. 22, 2020

    - The Wall Street Journal Interactive Edition

Rates »

Link to MarketWatch's Slice.